share_log

Interested In Xuchang KETOP Testing Research InstituteLtd's (SZSE:003008) Upcoming CN¥0.30 Dividend? You Have Four Days Left

Interested In Xuchang KETOP Testing Research InstituteLtd's (SZSE:003008) Upcoming CN¥0.30 Dividend? You Have Four Days Left

对许昌开拓测试研究所有限公司(深圳证券交易所:003008)即将派发的0.30元人民币股息感兴趣吗?你还剩四天
Simply Wall St ·  05/22 19:44

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Xuchang KETOP Testing Research Institute Co.,Ltd (SZSE:003008) is about to trade ex-dividend in the next 4 days. The ex-dividend date is usually set to be one business day before the record date which is the cut-off date on which you must be present on the company's books as a shareholder in order to receive the dividend. The ex-dividend date is important because any transaction on a stock needs to have been settled before the record date in order to be eligible for a dividend. Accordingly, Xuchang KETOP Testing Research InstituteLtd investors that purchase the stock on or after the 27th of May will not receive the dividend, which will be paid on the 27th of May.

熟悉我们的读者都知道,我们喜欢分红派息,因此看到开普检测(股票代码:003008.SZ)即将在接下来的4天内交易除息的消息令人兴奋。除息日通常设定为登记日前一业务日,即您必须作为股东出现在公司账簿上才能获得股息的截止日期。除息日非常重要,因为任何在股票上的交易都需要在登记日之前结算才能有资格获得股息。因此,自5月27日以后购买开普检测股票的投资者将无法获得即将于5月27日支付的股息。

The company's upcoming dividend is CN¥0.30 a share, following on from the last 12 months, when the company distributed a total of CN¥0.30 per share to shareholders. Based on the last year's worth of payments, Xuchang KETOP Testing Research InstituteLtd has a trailing yield of 1.3% on the current stock price of CN¥22.31. Dividends are an important source of income to many shareholders, but the health of the business is crucial to maintaining those dividends. As a result, readers should always check whether Xuchang KETOP Testing Research InstituteLtd has been able to grow its dividends, or if the dividend might be cut.

公司即将分派的每股股息为人民币0.30元,上一年度公司向股东分配了总计人民币0.30元的股息。根据去年的分红,开普检测在目前的股价22.31元人民币上有1.3%的年度股息率。分红是许多股东的重要收入来源,但企业的健康状况对于维持这些股息至关重要。因此,读者应始终检查开普检测是否能够增加其股息或是否需要削减其股息。

Dividends are typically paid from company earnings. If a company pays more in dividends than it earned in profit, then the dividend could be unsustainable. Fortunately Xuchang KETOP Testing Research InstituteLtd's payout ratio is modest, at just 43% of profit. Yet cash flow is typically more important than profit for assessing dividend sustainability, so we should always check if the company generated enough cash to afford its dividend. Dividends consumed 72% of the company's free cash flow last year, which is within a normal range for most dividend-paying organisations.

通常,股息是从公司的盈利中支付的。如果公司支付的股息超过其盈利,则股息可能是不可持续的。幸运的是,开普检测的派息比率很适中,只有43%。然而,现金流通常比盈利更重要,以评估股息的可持续性,因此我们应始终检查公司是否产生了足够的现金来支付其股息。开普检测去年的自由现金流消耗了公司自由现金流的72%,这是大多数分红机构的正常区间。

It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.

看到股息既有盈利也有现金流的覆盖是令人鼓舞的。这通常表明股息是可持续的,只要收益没有急剧下降。

Click here to see how much of its profit Xuchang KETOP Testing Research InstituteLtd paid out over the last 12 months.

单击此处,查看开普检测上一年度支付的盈利比率。

historic-dividend
SZSE:003008 Historic Dividend May 22nd 2024
深圳证券交易所代码:003008 历史分红:2024年5月22日

Have Earnings And Dividends Been Growing?

收益和股息一直在增长吗?

Businesses with shrinking earnings are tricky from a dividend perspective. If earnings fall far enough, the company could be forced to cut its dividend. Xuchang KETOP Testing Research InstituteLtd's earnings per share have fallen at approximately 17% a year over the previous five years. When earnings per share fall, the maximum amount of dividends that can be paid also falls.

从股息的角度看,收益萎缩的企业很麻烦。如果收益下降得足够快,公司可能会被迫削减股息。开普检测的每股收益在过去五年中下降了约17%。当每股收益下降时,可以支付的最大股息金额也会下降。

The main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. Xuchang KETOP Testing Research InstituteLtd's dividend payments per share have declined at 21% per year on average over the past three years, which is uninspiring. It's never nice to see earnings and dividends falling, but at least management has cut the dividend rather than potentially risk the company's health in an attempt to maintain it.

大多数投资者评估公司的股息前景的主要方式是检查股息历史增长率。开普检测的每股股息支付,在过去三年中平均下降了21%,这并不令人鼓舞。看到收益和股息下降并不是件好事,但至少管理层已经削减了股息,而不是为了维持股息而可能危及公司的健康。

Final Takeaway

最后的结论

From a dividend perspective, should investors buy or avoid Xuchang KETOP Testing Research InstituteLtd? Its earnings per share have been declining meaningfully, although it is paying out less than half its income and more than half its cash flow as dividends. Neither payout ratio appears an immediate concern, but we're concerned about the earnings. To summarise, Xuchang KETOP Testing Research InstituteLtd looks okay on this analysis, although it doesn't appear a stand-out opportunity.

从股息的角度看,投资者应该买还是避开开普检测?其每股收益已经明显下降,虽然其收入的支付比例不到一半,但其现金流的支付比例超过一半。支付比率似乎都不是立即的问题,但我们担心收益。总之,开普检测在这方面看起来还可以,但并不是一个杰出的机会。

With that being said, if dividends aren't your biggest concern with Xuchang KETOP Testing Research InstituteLtd, you should know about the other risks facing this business. We've identified 3 warning signs with Xuchang KETOP Testing Research InstituteLtd (at least 1 which makes us a bit uncomfortable), and understanding these should be part of your investment process.

话虽如此,如果分红不是投资者最关心的问题,他们应该了解开普检测业务面临的其他风险。我们已经确认了开普检测的三个警告信号(至少有一个让我们感到有点不安),了解这些应该成为您的投资过程的一部分。

A common investing mistake is buying the first interesting stock you see. Here you can find a full list of high-yield dividend stocks.

一个常见的投资错误是购买你看到的第一个有趣的股票。在这里,您可以找到高股息股票的完整列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发